-
Combination of CDK4/6 with BET-bromodomain and PI3K/mTOR inhibitors in medulloblastoma in vitro and in vivo
Study
EGAS00001006286
-
OAC WGS
Study
EGAS00001006470
-
RP-1843 Arcagen - Gastrointestinal rare cancers (GI)
Study
EGAS00001006299
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001006306
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__clear_cell_renal_cell_carcinoma___2
Study
EGAS00001003542
-
Placebo-only arm transcriptomic analysis of the phase 3 PROTECT clinical trial
Study
EGAS00001006344
-
Clonal dominance defines metastatic dissemination in pancreatic cancer
Study
EGAS00001006358
-
Reliable assessment of telomere maintenance mechanisms in neuroblastoma
Study
EGAS00001006510
-
Genomic landscape and molecularly-informed therapy in thymic carcinoma and other advanced thymic epithelial tumors (H021, HIPO)
Study
EGAS00001006408
-
Renal Cell Carcinoma Tumors From S-TRAC trial (NCT00375674) Whole Transcriptome Sequencing
Study
EGAS00001006528
-
Detection and genomic analysis of BRAF fusions in Juvenile Pilocytic Astrocytoma through the combination and integration of multi-omic data
Study
EGAS00001006388
-
in silico drug target prediction for melanoma
Study
EGAS00001006463
-
Ovarian carcinosarcoma genomics and eribulin response
Study
EGAS00001006555
-
Dedifferentiated_Melanoma_RNAseq
Study
EGAS00001003601
-
Proteogenomics reveals two distinct biological pilocytic astrocytoma subgroups
Study
EGAS00001006402
-
Repurposing azacitidine and carboplatin to prime immune checkpoint blockade-resistant melanoma for anti-PD-L1 re-challenge
Study
EGAS00001006419
-
Repurposing azacitidine and carboplatin to prime immune checkpoint blockade-resistant melanoma for anti-PD-L1 re-challenge
Study
EGAS00001006420
-
Long-read sequencing of diagnosis and post-therapy medulloblastoma reveals complex rearrangement patterns and epigenetic signatures
Study
EGAS00001006576
-
Genome and transcriptome sequence data from a angiosarcoma tumor patient
Dataset
EGAD00001015272
-
ctDNA quantification in Ewing sarcoma patients
Study
EGAS00001006433
-
Somatic mutations predict an aggressive phenotype in meningioma but do not drive grade progression
Study
EGAS00001006585
-
T cell reactivity of MHC epitopes
Study
EGAS00001006445
-
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases
Study
EGAS00001003672
-
OAC RNASeq
Study
EGAS00001006468
-
OAC scRNASeq
Study
EGAS00001006469